AnalystsInsight

Jim Kelleher (Argus Research): Analyst Track Record and Price‑Target Accuracy

How often Jim Kelleher’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 627 ratings, compared with the average Wall Street analyst.

3 min readHow we research

Key takeaways

  • Jim Kelleher ranks #28 of 1,000 analysts in Exent’s scoring (5.0★).
  • 58.7% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 92 days; 67.1% of calls were up 12 months later.
  • Most‑covered stocks: NVDA, ASML, DELL, WDC.

Jim Kelleher’s track record at a glance

Jim Kelleher of Argus Research ranks #28 of the 1,000 analysts Exent scores, with a 5.0★ rating and a focus on technology. Over a 7‑year lookback, 58.7% of Jim’s price targets were reached, 6.3 points above the 52.4% average across all analysts.

MetricJim KelleherAll analysts
Price‑target hit rate58.7%52.4%
Median days to hit target92 days91 days
Calls up after 12 months67.1%64.0%
Median 12‑month return of calls+18.7%+13.4%
Hit rate, last 2 years69.5%—
Average worst drop after a call−19.8%—
Ratings in the sample627—
Stocks covered66—

How fast price targets were reached

Time to reach the targetJim Kelleher
Under 30 days16.0%
30–90 days33.0%
90–180 days26.1%
Over 180 days24.8%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Jim Kelleher covers most

StockRatings in the sample
NVDA26
ASML15
DELL14
WDC14
NTAP13
AAPL13
KLAC12
GLW12

In the past year Jim’s ratings were 91% Buy, 9% Hold and 0% Sell.

Recent ratings (shown with a 30-day delay)

DateStockActionRatingPrice target
Sep 11, 2026NTAPReiterated: BuyBuy$225.00
Sep 10, 2026CIENReiterated: BuyBuy$550.00
Sep 4, 2026HPEReiterated: BuyBuy$70.00
Aug 27, 2026HPQReiterated: BuyBuy$34.00
Aug 20, 2026ADIMaintained: BuyBuy$0.00
Aug 17, 2026AMATReiterated: BuyBuy$600.00
Aug 13, 2026CSCOReiterated: BuyBuy$150.00
Aug 12, 2026SMCIMaintained: HoldHold$0.00
Aug 12, 2026CRWVReiterated: BuyBuy$150.00
Aug 11, 2026VIAVReiterated: BuyBuy$66.00
Aug 7, 2026SNDKUpgraded: BuyBuy$1600.00
Aug 6, 2026VSHReiterated: BuyBuy$48.00
  • Sep 11, 2026
    Stock
    NTAP
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $225.00
  • Sep 10, 2026
    Stock
    CIEN
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $550.00
  • Sep 4, 2026
    Stock
    HPE
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $70.00
  • Aug 27, 2026
    Stock
    HPQ
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $34.00
  • Aug 20, 2026
    Stock
    ADI
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $0.00
  • Aug 17, 2026
    Stock
    AMAT
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $600.00
  • Aug 13, 2026
    Stock
    CSCO
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $150.00
  • Aug 12, 2026
    Stock
    SMCI
    Action
    Maintained: Hold
    Rating
    Hold
    Price target
    $0.00
  • Aug 12, 2026
    Stock
    CRWV
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $150.00
  • Aug 11, 2026
    Stock
    VIAV
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $66.00
  • Aug 7, 2026
    Stock
    SNDK
    Action
    Upgraded: Buy
    Rating
    Buy
    Price target
    $1600.00
  • Aug 6, 2026
    Stock
    VSH
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $48.00

Live ratings from Jim Kelleher and the other top‑ranked analysts, and the stocks where they agree, are in Exent Stocks Radar.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 13, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Stocks Radar shows Jim Kelleher’s live ratings and those of the other top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Jim Kelleher ranks #28 of 1,000 with a 5.0★ rating. 58.7% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 67.1% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Jim Kelleher’s success rate is 71.7% by the ranking source and 58.7% by Exent’s price-target hit-rate backtest, with a median of 92 days to reach a target.

Jim Kelleher (Argus Research) covers 66 stocks, mostly in technology. The most frequently rated are NVDA, ASML, DELL, WDC, NTAP.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full Gems access· full Gems access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.